The Aortic Valve Replacement Devices Market refers to the global industry focused on medical devices used to replace damaged or diseased aortic valves in patients suffering from conditions such as aortic stenosis or aortic regurgitation. These devices restore normal blood flow from the heart to the body, improving survival rates and quality of life.
In 2025, the aortic valve replacement devices market reached a value of USD 9.57 Billion. With increasing cardiovascular disease prevalence and technological innovation in minimally invasive procedures, the market is projected to grow at a CAGR of 6.50% from 2026 to 2035, reaching approximately USD 17.96 Billion by 2035.
The growing elderly population, rising diagnosis rates of valvular heart diseases, and expanding adoption of transcatheter technologies are key drivers of market expansion.
How Big Is the Aortic Valve Replacement Devices Market and What Is Its Forecast?
The Aortic Valve Replacement Devices Market is experiencing strong momentum due to the increasing incidence of aortic stenosis, particularly among aging populations. Degenerative valve diseases are more common in individuals over 65, and as life expectancy increases, so does the demand for advanced cardiac interventions.
Growth drivers include:
Rising geriatric population
Increasing prevalence of valvular heart diseases
Technological advancements in transcatheter aortic valve replacement (TAVR)
Reduced surgical risks through minimally invasive techniques
Expanding healthcare infrastructure in emerging economies
By 2035, the market is expected to nearly double in value, reflecting sustained demand for both surgical and transcatheter valve replacement procedures.
What Is Aortic Valve Replacement and When Is It Needed?
Aortic valve replacement (AVR) is a surgical or minimally invasive procedure performed to replace a malfunctioning aortic valve. The aortic valve regulates blood flow from the left ventricle to the aorta. When the valve becomes narrowed (stenosis) or leaks (regurgitation), it can lead to serious complications such as heart failure.
Symptoms requiring intervention include:
Shortness of breath
Chest pain
Fatigue
Fainting spells
Irregular heartbeat
Modern replacement devices are designed to improve durability, reduce procedural risks, and enhance patient recovery.
Market Breakup by Surgery Type
Open Surgery
Open surgical aortic valve replacement (SAVR) has long been the standard treatment for severe aortic stenosis. It involves opening the chest and replacing the valve directly. Although highly effective, recovery time is longer compared to minimally invasive methods.
This segment remains significant, particularly for younger patients who require durable mechanical valves.
Minimally Invasive Surgery
Minimally invasive techniques, including transcatheter procedures, are rapidly gaining market share. These procedures involve smaller incisions or catheter-based delivery systems, resulting in:
Shorter hospital stays
Reduced postoperative complications
Faster recovery
Lower procedural risk for elderly patients
The growing preference for minimally invasive options is one of the strongest drivers of market growth.
Market Breakup by Product Type
Transcatheter Aortic Valve
Transcatheter Aortic Valve Replacement (TAVR) devices dominate the Aortic Valve Replacement Devices Market. These valves are delivered via catheter, typically through the femoral artery, eliminating the need for open-heart surgery.
TAVR has expanded beyond high-risk patients to include intermediate- and low-risk groups, significantly increasing procedure volumes worldwide.
Sutureless Aortic Valve Replacement (SUAVR)
Sutureless valves are designed for quicker implantation during minimally invasive surgery. These devices reduce operative time and simplify procedures, particularly in elderly or high-risk patients.
While currently smaller than the TAVR segment, SUAVR is expected to grow steadily due to procedural efficiency benefits.
Market Breakup by End Use
Hospitals
Hospitals account for the largest share of the Aortic Valve Replacement Devices Market. Advanced surgical infrastructure, hybrid operating rooms, and specialized cardiac teams make hospitals the primary setting for AVR procedures.
Ambulatory Surgical Centres
Ambulatory surgical centres (ASCs) are gradually increasing their share as minimally invasive technologies reduce recovery times. However, complex valve procedures are still primarily performed in hospital environments.
Others
This category includes specialty cardiac clinics and research institutions conducting clinical trials and device innovation studies.
Regional Analysis of the Aortic Valve Replacement Devices Market
North America
North America leads the market due to high cardiovascular disease prevalence, advanced healthcare infrastructure, and rapid adoption of TAVR procedures. The United States is a major contributor, supported by favorable reimbursement policies and ongoing clinical research.
Europe
Europe holds a strong market position, driven by aging populations and well-established public healthcare systems. Countries such as Germany, France, and the United Kingdom are key contributors.
Asia Pacific
Asia Pacific is expected to witness the fastest growth over the forecast period. Increasing healthcare investments, rising awareness of valvular diseases, and improving access to advanced cardiac procedures are fueling regional growth.
Latin America
Latin America shows moderate growth supported by expanding healthcare facilities and increasing adoption of minimally invasive techniques.
Middle East and Africa
Gradual improvements in healthcare infrastructure and medical tourism are supporting market expansion in this region.
Who Are the Leading Companies in the Aortic Valve Replacement Devices Market?
The competitive landscape is shaped by innovation, product approvals, and strategic partnerships. Key players include:
Boston Scientific Corporation
Corcym S.r.l
Edwards Lifesciences Corporation
Medtronic plc
Artivion, Inc.
Abbott Laboratories
These companies focus on advanced valve technologies, expanding clinical trials, and improving device durability and safety profiles.
What Technological Innovations Are Driving Growth?
Expansion of TAVR indications to lower-risk patients
Improved valve durability and longevity
Reduced-profile delivery systems
Enhanced imaging guidance technologies
Development of retrievable and repositionable valves
These innovations are expanding patient eligibility and improving procedural outcomes.
What Challenges Does the Market Face?
Despite strong growth prospects, challenges include:
High procedure costs
Strict regulatory requirements
Risk of complications such as paravalvular leak
Need for long-term durability data
Limited access in developing regions
Addressing affordability and expanding training for cardiac specialists will be critical for future growth.
FAQs
. What is the current size of the Aortic Valve Replacement Devices Market?
The Aortic Valve Replacement Devices Market was valued at USD 9.57 Billion in 2025 and is projected to reach USD 17.96 Billion by 2035 at a CAGR of 6.50%.
. What factors are driving growth in the Aortic Valve Replacement Devices Market?
The Aortic Valve Replacement Devices Market is driven by rising aortic stenosis cases, aging populations, technological advancements in TAVR, and increasing adoption of minimally invasive procedures.
. Which product segment dominates the market?
Transcatheter aortic valves dominate the market due to their minimally invasive nature and expanding patient eligibility.
. Which region leads the market?
North America leads the market due to advanced cardiac care infrastructure and strong adoption of innovative valve technologies.
. What is the difference between TAVR and open surgery?
TAVR is a minimally invasive catheter-based procedure, while open surgery requires chest opening and longer recovery time.
